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Introduction
Homeostatic regulation in the CNS is a complex process that is 
critical for systemic physiological balance. Therefore, identifying 
the brain systems integrating internal and external signals is para-
mount to understanding how the CNS maintains body homeosta-
sis under diverse conditions. The hypothalamus is a vital center 
for body functions, including energy and skeletal homeostasis. Its 
functions include receiving and integrating complex peripheral 
signals and responding to them using humoral factors, autonom-
ic nerves, and neuronal and behavioral components. Recently, 
hypothalamic primary cilia, a solitary antenna-like extension of 
the plasma membrane, was suggested as an important organ-
elle for the regulation of body homeostasis (1, 2). Although these 
studies suggested the role of primary cilia in the arcuate nucleus 
of the hypothalamus (ARC) and melanocortin pathway–mediated 
weight regulation, the physiological roles of primary cilia in dif-
ferent hypothalamic nuclei remain poorly understood. Moreover, 
much less is known about the mechanism by which hypothalamic 
primary cilia mediate diverse homeostatic functions.
The ventromedial hypothalamus (VMH) is an oval-shaped 
hypothalamic nucleus located directly above the ARC that has 
been identified as a site for regulation of body weight and glu-
cose homeostasis (3). Early studies have shown that VMH lesions 
induced parasympathetic tone, leading to hyperinsulinemia and 
obesity (4, 5). Later, electrical stimulation experiments confirmed 
that the VMH is involved in the regulation of not only parasym-
pathetic, but also sympathetic nerve activity (6). Furthermore, 
research has shown that the VMH is engaged in other various 
homeostatic regulations, such as skeletal homeostasis, mood 
behaviors, and reproductive function (7–9). Interestingly, a recent 
report showed that primary cilia are expressed in the VMH and that 
the length of VMH primary cilia is dynamically changed by meta-
bolic conditions in which shorter cilia are dominant in metaboli-
cally unfavorable conditions such as obesity and leptin resistance 
(10). Though these dynamic changes suggest that VMH primary 
cilia might play key roles in the maintenance of body homeostasis, 
there is no report yet on functional roles of VMH primary cilia in 
regulating body homeostasis.
The intraflagellar transport 88 (IFT88) is a core member of 
IFT machinery (IFT B complex) that carries ciliary building blocks 
along microtubules during the assembly and maintenance of the 
cilium (11). Previously, conditional deletion of IFT88 was used to 
address cell- or tissue-specific primary cilia function (1, 12). In the 
present study, in order to gain insight into the functional roles of 
primary cilia in the VMH, we generated VMH-specific primary cil-
ia KO mice by crossing steroidogenic factor 1–Cre (SF-1–Cre) and 
floxed IFT88 (IFT88fl/fl) mice and investigated the homeostatic 
role of primary cilia in this nucleus. We also administrated bilat-
eral adeno-associated virus Cre (AAV-Cre) in IFT88fl/fl mice, spe-
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Primary cilia in the VMH are required to maintain normal body 
weight. Although the VMH has been identified as a brain site for 
energy homeostasis (19–21), it is not known whether VMH prima-
ry cilia play a role in the regulation of whole-body energy homeo-
stasis. To address this question, body weight was monitored 
weekly in male and female IFT88-KOSF-1 mice. Normal chow–fed 
(NC-fed) IFT88-KOSF-1 mice displayed significantly increased 
body weight compared with WT littermates (Figure 1C and Sup-
plemental Figure 5A). Similarly, IFT88-KOSF-1 male mice fed a 
high-fat diet (HFD) showed an obese phenotype (Supplemental 
Figure 6A). Dual-energy X-ray absorptiometry (DEXA) analysis 
revealed a distinct fat mass increment in IFT88-KOSF-1 mice (Fig-
ure 1D and Supplemental Figures 5B and 6B). In accordance with 
these findings, the subcutaneous white adipose tissue (s.c.WAT) 
and gonadal white adipose tissue (gWAT) areas of the IFT88-KOSF-1 
mice were significantly bigger than those of WT mice (Figure 1E). 
In addition, IFT88-KOSF-1 mice exhibited increases in the number 
of hypertrophic adipocytes, as revealed by histological analysis 
(Figure 1, F and G). Serum leptin levels were also increased in the 
IFT88-KOSF-1 mice (Figure 1H).
To provide further evidence in support of excluding potential 
peripheral effects and thus confirm that the obesity in IFT88-KOSF-1 
mice came directly from the absence of primary cilia in the VMH, 
we bilaterally injected AAV2-GFP (control) or AAV2-Cre-GFP into 
the VMH of IFT88fl/fl mice (Figure 1I). Bilateral Cre virus injection 
induced VMH-specific knockdown (KD) of primary cilia (Figure 1I). 
The KD mice exhibited the obese phenotype seen in IFT88-KOSF-1 
mice (Figure 1, J and K), suggesting the primary cilia in the VMH 
are critical organelles for maintaining normal energy homeostasis.
Decreased sympathetic tone is the major cause of obesity in 
IFT88-KOSF-1 mice. To determine potential factors responsible 
for inducing obesity in IFT88-KOSF-1 mice, we monitored several 
metabolic parameters using indirect calorimetry (20, 22). Body 
weight–matched 12-week-old WT and IFT88-KOSF-1 littermates 
were maintained on a NC diet and subjected to metabolic cage 
studies (Figure 2A). Although food intake of IFT88-KOSF-1 mice 
was not markedly different from that of WT littermates, their VO2, 
VCO2, and energy expenditure (EE) were significantly lower, espe-
cially during the dark cycle (Figure 2, B–E). Under HFD-feeding 
conditions, the obesity phenotype of the IFT88-KOSF-1 mice was 
more apparent from early ages, with a significant increase in food 
intake and lower VO2, VCO2, and EE (Supplemental Figure 6, C–J). 
The expression of hypothalamic orexigenic Agrp significantly 
increased and anorexigenic Pomc decreased without changes in 
Npy expression (Figure 2F and Supplemental Figure 6K). Physi-
cal activity was comparable between WT and IFT88-KOSF-1 mice 
regardless of the type of diet (Figure 2G and Supplemental Figure 
6, L and M). Together, these results highlight that primary cilia in 
the VMH are required for maintaining normal energy balance.
Interscapular brown adipose tissue (iBAT) plays an important 
roles in controlling basal metabolic rate, including EE, and the 
VMH is a brain region that regulates sympathetic tone to the iBAT 
(20, 22, 23). Uncoupling protein 1 (UCP1), a key regulator of ther-
mogenesis in iBAT, is well known to be activated by sympathetic 
tone (24). Therefore, we determined whether the decreased EE 
in IFT88-KOSF-1 mice was linked to iBAT dysfunction. We found 
that the VMH primary cilia KO mice had hyperplasia in the iBAT, 
cifically targeting the VMH, to overcome any potential peripheral 
effect of the SF-1–Cre line.
We found that normal primary cilia function in the VMH is 
required for maintaining normal sympathetic nerve activity. Spe-
cific deletion of the primary cilia using the Cre-loxP system or 
bilateral AAV-Cre injection into the VMH caused metabolic dys-
regulations and abnormal skeletal homeostasis. Thus, this study 
suggests that VMH primary cilia play critical roles in regulating 
energy and skeletal homeostasis through modulation of the sym-
pathetic nervous system (SNS).
Results
Specific deletion of primary cilia in the VMH. To examine the physi-
ological role of primary cilia in the VMH, we used the conditional 
KO system and disrupted intraflagellar transport (IFT) machin-
ery by deleting the Ift88 gene, an essential factor for primary cilia 
formation, specifically in the SF-1 neurons of the VMH. Breeding 
IFT88fl/fl with SF-1–Cre mice resulted in mice with deficiency of 
primary cilia solely in those neurons (Figure 1, A and B) (13, 14). 
While the number of neurons expressing primary cilia and the 
length of the cilia were comparable in the paraventricular nucleus 
of the hypothalamus (PVN), dorsomedial hypothalamus (DMH), 
lateral hypothalamus (LH), and ARC between WT and IFT88-
KOSF-1 mice, these factors were markedly reduced in the VMH of 
IFT88-KOSF-1 mice (Figure 1, A and B, and Supplemental Figure 1; 
supplemental material available online with this article; https://
doi.org/10.1172/JCI138107DS1).
Deletion of IFT88 did not affect overall brain morphology, 
including brain width and length (Supplemental Figure 2, A and B). 
Neuronal cytoarchitecture of the VMH and expression of SF-1 in 
the VMH were also intact in IFT88-KOSF-1 mice (Supplemental Fig-
ure 2, C–E). In addition, the numbers and soma size of SF-1 neurons 
were comparable between WT and IFT88-KOSF-1 mice (Supplemen-
tal Figure 2, F–H). Together, these results indicate that the VMH of 
IFT88-KOSF-1 mice was intact and the neurons were viable. Next, 
we performed a coexpression analysis of primary cilia and SF-1 via 
immunohistochemistry on peripheral tissues, which express EGFP 
under the regulatory elements of the SF-1 gene through the BAC 
transgene (15). For this method, we used the antibodies somatosta-
tin receptor 3 (SSTR3), acetylated tubulin (Ac-Tub), and adenylyl 
cyclase III (ACIII), which are all well-known markers of primary 
cilia. Consistent with results from previous studies (16–18), prima-
ry cilia in the SF-1–expressing peripheral cells, such as the pituitary 
gonadotrophs, adrenal cortex, ovary theca, and testis Leydig cell, 
were not detected (Supplemental Figure 3, A–D). The pituitary and 
adrenal glands, ovary, and testis were anatomically intact, and 
circulating corticosterone, aldosterone, and estradiol (E2) levels 
were also comparable between WT and IFT88-KOSF-1 mice (Sup-
plemental Figure 4, A–H) (19). Furthermore, comparable litter size 
and litter per month, coupled with no differences in organ structure 
and steroid hormone levels, confirmed that the IFT88-KOSF-1 mice 
have normal hypothalamic-pituitary-adrenal (HPA) and hypotha-
lamic-pituitary-gonadal (HPG) axes (Supplemental Table 1). These 
results indicate that the deletion of IFT88 in the SF-1 neurons of the 
VMH using SF-1–Cre leads to specific primary cilia deletion only 
in those neurons, without developmental or detectable hormonal 
changes in the brain and the periphery.
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were upregulated (Figure 2M). These results highly suggest that 
VMH primary cilia play an important role in maintaining normal 
iBAT function, potentially through sympathetic nerve activity. 
To directly confirm whether VMH primary cilia are involved in 
sympathetic regulation, we evaluated serum norepinephrine (NE) 
levels of mice age from 8 to 14 weeks, when the body weight of 
WT and IFT88-KOSF-1 mice were comparable. The IFT88-KOSF-1 
mice showed a tendency of decreased NE levels from the first 8 
weeks, with significantly different levels at 12 and 14 weeks (Fig-
ure 2N). In addition, correlation analysis between NE and body 
and H&E staining confirmed higher lipid infiltration in the IFT88-
KOSF-1 mice with lower mitochondria contents (Figure 2, H and 
I). In addition, immunohistochemistry and Western blot results 
showed markedly decreased UCP1 expression in IFT88-KOSF-1 
mice (Figure 2, J–L). Furthermore, thermogenic or mitochondri-
al function–related genes, such as Ucp1, peroxisome proliferator–
activated receptor γ coactivator 1α (Pgc1α), type II iodothyronine 
deiodinase (Dio2), and mitochondrial transcription factor A 
(Tfam), were downregulated, whereas genes involved in de novo 
lipogenesis, including PPARγ and fatty acid synthase (FASN), 
Figure 1. Deletion of primary cilia in the VMH leads to obesity. (A) Primary cilia were visualized by ACIII (green) in the VMH of WT and IFT88-KOSF-1 mice. 
Scale bar: 10 μm. (B) Length and percentage of the VMH cilia shown in A. **P < 0.01; ***P < 0.001, Student’s t test. (C) Left: weekly body weight of WT and 
IFT88-KOSF-1 mice fed on NC. Right: representative photographs of 18-week-old male mice on NC diet. *P < 0.05, 2-way ANOVA. (D) Left: fat and lean mass 
were measured by NMR. Right: representative DEXA image. **P < 0.01, Student’s t test. (E) Representative s.c.WAT and gWAT from WT and IFT88-KOSF-1 
mice. Scale bars: 0.5 mm. (F and G) H&E staining (F) and adipocyte cell surface (G) of gWAT. Adipocyte cell surface measured by ImageJ. Scale bar: 50 μm. 
***P < 0.001, 2-way ANOVA. (H) Serum leptin levels in WT and IFT88-KOSF-1 mice at 14 week of age. **P < 0.01, Student’s t test. (I) Left: schematic show-
ing bilateral viral injection into VMH. Right: schematic for AAV2-GFP and AAV2-Cre-GFP constructs used for viral injection (upper) and validation images 
of primary cilia KD in VMH (lower). Scale bars: 0.1 mm (yellow); 10μm (white). (J) Weekly body weight after injection with AAV2-GFP or AAV2-Cre-GFP into 
the VMH. ***P < 0.001, 2-way ANOVA. (K) Left: body compositions 10 weeks after injection of AAV2-GFP or AAV2-Cre-GFP. Right: representative DEXA 
images. ***P < 0.001, Student’s t test. Number of animals examined is expressed in parentheses in each graph. Results are expressed as mean ± SD.
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STAT3 expression, leptin-induced p-STAT3 activation was signifi-
cantly impaired, specifically in the VMH where the primary cilia 
were removed (Figure 3, C–F). To further confirm the direct role 
of VMH primary cilia in leptin action, we used metabolic cham-
bers to monitor metabolic parameters in body weight–matched 
WT and IFT88-KOSF-1 littermates after leptin administration (Fig-
ure 3G). The IFT88-KOSF-1 mice exhibited resistance to the reduc-
tion in food intake and increase in EE induced by leptin (Figure 
3, H–K). Together, these results suggest that the primary cilia in 
SF-1 neurons of the VMH are necessary for normal leptin action 
and leptin resistance in IFT88-KOSF-1 mice is not a secondary con-
sequence of obesity.
VMH-specific deletion of primary cilia leads to glucose and insu-
lin intolerance. We next determined whether the primary cilia 
expressed in SF-1 neurons of the VMH are involved in the regula-
tion of glucose homeostasis and insulin sensitivity. IFT88-KOSF-1 
mice exhibited significantly elevated serum glucose and insu-
lin levels (Figure 4, A and B). Also, IFT88-KOSF-1 mice showed 
impaired tolerance of glucose and insulin, without significant 
changes in glucose-induced insulin secretion (Figure 4, C–E). 
These results indicate that primary cilia in the VMH are required 
for the regulation of normal glucose and insulin homeostasis.
Gene expression analyses in liver showed increased 
expression of gluconeogenic glucose 6-phosphatase (G6Pase) 
and phosphoenolpyruvate carboxykinase (PEPCK) as well as 
decreased expression of glycolytic pyruvate kinase (Pklr), imply-
ing that aberrant gluconeogenesis might contribute to the high 
glucose and insulin insensitivity in IFT88-KOSF-1 mice (Figure 
4F). In addition, liver from the IFT88-KOSF-1 mice exhibited 
evident steatosis along with a significant increment in hepatic 
lipogenic genes (Figure 4, G and H). The effects of both glucose 
and insulin intolerance were also distinct in AAV-Cre–mediated 
VMH-specific IFT88 KD mice, confirming that the VMH primary 
cilia play an important role for whole-body glucose homeostasis 
and insulin sensitivity (Figure 4, I and J).
Decreased sympathetic activity leads to high bone density in 
IFT88-KOSF-1 mice. Evidence from animal and human studies 
demonstrated that changes in the SNS are linked to alterations 
in bone density. Moreover, the VMH is known to control bone 
homeostasis (27–30). Considering the decreased sympathetic 
tone and leptin resistance in IFT88-KOSF-1 mice, we thus deter-
weight showed that the NE levels were inversely correlated with 
body weight only in IFT88-KOSF-1 mice (Figure 2O), indicating 
that decreased sympathetic activity would be one of the factors 
responsible for decreased EE and iBAT function.
If decreased sympathetic activity is a major cause of the meta-
bolic phenotypes of IFT88-KOSF-1 mice, it is possible that the intro-
duction of sympathomimetics would countervail the metabolic dis-
orders. To this end, we administered mice daily with isoproterenol 
(ISO), a β-adrenoreceptor agonist, for 2 weeks at a concentration 
that does not disturb body weight for both WT and IFT88-KOSF-1 
mice (Supplemental Figure 7A). The marked difference of the VO2, 
VCO2, and EE levels induced by VMH primary cilia KO as shown 
in Figure 2 was normalized by the ISO treatment without changing 
locomotor activity (Supplemental Figure 7, B–E). These results con-
firm that the metabolic phenotypes shown in IFT88-KOSF-1 mice 
primarily come from the decreased sympathetic activity.
Primary cilia are required for normal leptin sensitivity in the VMH. 
In the hypothalamus, adipokine leptin suppresses food intake 
and increases sympathetic tone and EE (25, 26). The effects of 
increased food intake and decreased sympathetic tone and EE in 
IFT88-KOSF-1 mice led us to hypothesize that the VMH primary cilia 
may be important factors for leptin action. To address this propo-
sition, we first monitored serum leptin levels of WT and IFT88-
KOSF-1 mice at 8 to 14 weeks, a period when WT and IFT88-KOSF-1 
littermates show comparable body weight. Surprisingly, the IFT88-
KOSF-1 mice showed markedly higher leptin levels from 12 weeks 
along with a strong trend of increasing leptin levels even from 8 
to 10 weeks, indicating that ciliary defects in the VMH may lead 
to primary leptin resistance (Table 1). Next, we examined leptin 
sensitivity either by measuring rebound food intake or by monitor-
ing the feeding response to leptin injection after an 18-hour fast. 
Results indicated that the IFT88-KOSF-1 mice showed significantly 
increased rebound food intake and, following leptin administra-
tion, exhibited blunted response to the injected leptin, as demon-
strated by significantly increased food intake (Figure 3, A and B).
In addition, leptin activates STAT3, and the phosphorylation 
of STAT3 (p-STAT3) in the brain is an indicator of leptin sensi-
tivity. Thus, we examined the basal hypothalamic STAT3 level 
together with p-STAT3. Although there was no change in basal 
Figure 2. VMH primary cilia are important for regulation of EE and BAT 
function. (A) Comparable body weights of WT and IFT88-KOSF-1 litter-
mates at 12 week of age. (B) Cumulative daily food intake on NC diet. (C–E) 
Temporal changes of VO2 (C), VCO2 (D), and EE (E) in WT and IFT88-KOSF-1 
littermates. *P < 0.05 (red asterisks), 2-way ANOVA; **P < 0.01, Student’s 
t test. (F) Hypothalamic Pomc, Agrp, and Npy expression. *P < 0.05, 
Student’s t test. (G) Temporal changes of movement in WT and IFT88-
KOSF-1 littermates. (H) Morphology and H&E staining of the iBAT from WT 
and IFT88-KOSF-1 littermates. Scale bar, 0.5mm for yellow and 50μm for 
black. (I) Mitochondria DNA contents in iBAT. **P < 0.01, Student’s t test. 
(J) Immunohistochemistry for UCP1 in iBAT of WT and IFT88-KOSF-1 mice. 
Scale bar: 100μm. (K and L) Western blot (K) and relative fold changes 
of protein levels (L) for UCP1. ***P < 0.001, Student’s t test. (M) Rela-
tive gene expression levels in iBAT. *P < 0.05; **P < 0.01; ***P < 0.001, 
Student’s t test. (N) Age-dependent serum NE levels in WT and IFT88-
KOSF-1 mice. *P < 0.05; **P < 0.01, 2-way ANOVA. (O) Correlation analysis 
between serum NE and body weight of WT and IFT88-KOSF-1 mice. Number 
of animals examined is expressed parentheses in each graph. Results are 
expressed as mean ± SD.
Table 1. Serum leptin level in 8- to 14-week-old WT and  
IFT88-KOSF-1 mice
Week WT IFT88-KOSF-1
(n = 6) (n = 6)
8 2.932 ± 1.173 3.198 ± 2.466
10 3.616 ± 1.496 5.954 ± 3.336
12 4.097 ± 2.125 10.400 ± 2.569A
14 4.790 ± 2.658 10.480 ± 4.699A
Age-dependent serum leptin levels. Note the significant difference in 
leptin levels from 12 week when the WT and IFT88-KOSF-1 mice have 
comparable body weight. Data are expressed as mean ± SD. AP < 0.05, 
2-way ANOVA.
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mined whether the VMH primary cilia are important factors in 
maintaining skeletal homeostasis.
We performed age-dependent DEXA analysis to examine bone 
parameters. Interestingly, the long bones of the male IFT88-KOSF-1 
mice showed increased bone mineral density (BMD), bone mineral 
content (BMC), bone volume (BV), and bone area (BA) compared 
with that of WT littermates, independent of the effect of obesi-
ty (Figure 5, A–D). Similarly, the female IFT88-KOSF-1 mice also 
exhibited increased BMD, BMC, BV, and BA (Supplemental Figure 
8, A–D). The bone parameters examined were inversely correlat-
ed with serum NE only for IFT88-KOSF-1 mice (Figure 5, E–H). In 
addition, femur NE levels significantly decreased in IFT88-KOSF-1 
Figure 3. VMH primary cilia are required for leptin action. (A) Cumulative rebound food intake of 10-week-old littermates after overnight fasting for 
18 hours. *P < 0.05, 2-way ANOVA. (B) Rebound food intake of 12-week-old littermates after leptin administration. **P < 0.01, 2-way ANOVA. (C and D) 
Western blot (C) and relative fold changes of protein levels (D) for hypothalamic STAT3 in WT and IFT88-KOSF-1 mice. (E) Immunohistochemical analysis of 
p-STAT3 activation after leptin injection. Ten-week-old WT and IFT88-KOSF-1 mice were used for analysis. Note that p-STAT3–positive cells are specifically 
decreased in VMH. Scale bar: 100 μm. (F) Relative p-STAT3 expression in VMH or ARC. ***P < 0.001, Student’s t test. (G) Body weight for 12-week-old WT 
and IFT88-KOSF-1 littermates used for metabolic cage study shown in (H–K). (H) Cumulative food intake after leptin administration measured in metabolic 
chamber. **P < 0.01, 2-way ANOVA. (I–K) Temporal change of VO2 and its average (I), VCO2 and its average (J), and EE and its average (K). *P < 0.05, Stu-
dent’s t test. Number of animals examined is expressed in parentheses in each graph. Data are expressed as mean ± SD.
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mice, indicating that the decreased sympathetic activity may con-
tribute to the increased bone density in these mice (Figure 5I). μCT 
analysis recapitulated the DEXA data and showed increased BMD 
and BV in addition to thicker trabeculae in the IFT88-KOSF-1 mice 
(Figure 5, J and K). To further confirm that the VMH primary cilia 
are directly involved in the regulation of bone mass, we analyzed 
viral-mediated VMH-specific IFT88 KD mice. Bilateral injection of 
AAV-Cre into the VMH of the IFT88fl/fl mice resulted in high bone 
density in the KD femur, indicating a critical role for VMH primary 
cilia in the regulation of bone homeostasis (Table 2 and Figure 5, L 
and M). Overall, these results identify normal VMH primary cilia as 
a requirement for bone mass homeostasis.
It has been shown that the effect of the SNS on bone homeosta-
sis is mediated through β-adrenergic receptors (β-ARs), and sev-
Figure 4. Impaired VMH-primary 
cilia result in glucose and insulin 
intolerance. (A and B) Blood glucose 
(A) and insulin (B) levels in WT and 
IFT88-KOSF-1 littermates at 12 week of 
age. *P < 0.05, Student’s t test. (C) 
Left: GTT between WT and IFT88-
KOSF-1. Right: AUC from GTT. *P < 0.05; 
**P < 0.01, 2-way ANOVA. (D) Left: 
ITT in indicated genotypes. Right: 
AUC for the ITT. *P < 0.05; **P < 
0.01; ***P < 0.001, 2-way ANOVA. (E) 
Glucose-stimulated insulin secretion 
(GSIS) during GTT experiments. (F) 
Relative expression of gluconeogenic 
genes in the liver. **P < 0.01; ***P < 
0.001, Student’s t test. (G) H&E stain-
ing of liver from WT and IFT88-KOSF-1 
mice. Scale bar: 50μm. (H) Relative 
expression of lipogenesis-related 
genes in the liver. *P < 0.05; **P < 
0.01; ***P < 0.001, Student’s t test. 
(I) GTT (left) and its AUC (right) in 
viral-mediated VMH-specific IFT88 
KD models. *P < 0.05, 2-way ANOVA. 
(J) ITT (left) and its AUC (right) in 
viral-mediated VMH-specific IFT88 
KD models. *P < 0.05; **P < 0.01, 
2-way ANOVA. Number of animals 
examined is expressed parentheses 
in each graph. Data are expressed as 
mean ± SD.
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ISO treatment (Figure 6, A–D). In addition, using μCT analysis, 
we confirmed the countervailing effect of ISO, as ISO treatment 
revealed no differences in BMD, bone volume/trabecular volume 
(BV/TV), bone surface (BS), trabecular thickness (Tb.Th.), trabec-
ular number (Tb.N.), and trabecular separation (Tb.Sp.) between 
WT and IFT88-KOSF-1 mice (Figure 6, E and F). These results indi-
cate that decreased sympathetic activity induced by primary cilia 
eral animal studies have demonstrated that β-blocker increased 
bone mass not only in normal, but also in ovariectomized condi-
tions (29–31). To investigate whether chronic β-AR agonist treat-
ment could offset the high bone mass shown in IFT88-KOSF-1 
mice, we administered mice daily with ISO for 2 weeks and mon-
itored bone parameters. The significantly increased basal BMD, 
BMC, BV, and BA shown in IFT88-KOSF-1 mice disappeared after 
Figure 5. Deletion of VMH primary cilia leads to bone mass increment. (A–D) DEXA analyses were performed at indicated ages and measured bone 
parameters. BMD (A), BMC (B), BV (C), and BA (D) levels of WT and IFT88-KOSF-1 mice. *P < 0.05; **P < 0.01, 2-way ANOVA. (E–H) Correlation between 
serum NE and BMD (E), BMC (F), BV (G), and BA (H) respectively. For correlation testing, linear regression models in R were utilized and R2 values were 
reported. (I) Femur NE level of WT and IFT88-KOSF-1 littermates at 16 weeks of age. ***P < 0.001, Student’s t test. (J) Representative μCT images of the 
femurs. The 12-week old WT and IFT88-KOSF-1 littermates were used for analyses. (K) BMD, BV/TV, BS, Tb.Th., Tb.N., and Tb.Sp. were analyzed using μCT 
from J. *P < 0.05; **P < 0.01, Student’s t test. (L) Representative μCT images of femurs in control (AAV2-GFP) and viral-mediated VMH-specific primary 
cilia KD (AAV2-Cre-GFP) mice. (M) BMD, BV/TV, BS, Tb.Th., Tb.N., and Tb.Sp. were analyzed using μCT from L. *P < 0.05, Student’s t test. Number of ani-
mals examined is expressed parentheses in each graph. Data are expressed as mean ± SD.
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Discussion
Deletion of VMH primary cilia by targeting the Ift88 gene using 
either SF-1–Cre or bilateral AAV-Cre injection resulted in met-
abolic dysregulations such as obesity, insulin/leptin resistance, 
impaired brown fat function, and increased fat mass. In addition, 
impaired primary cilia function in the VMH led to increased osteo-
blastic and decreased osteoclastic activities, resulting in high bone 
density. The VMH is known to regulate sympathetic activity, and 
decreased sympathetic activity is linked to reduction of metabolic 
rate and increase in bone density (6). Thus, we determined wheth-
er the VMH primary cilia play a critical role in controlling sympa-
thetic activity. The IFT88-KOSF-1 mice exhibited several indications 
of impaired sympathetic activity, including decreased EE, blunted 
brown fat function, and leptin resistance. They also demonstrated 
markedly lower levels of serum NE independent of changes in body 
weight. These results indicate that the VMH primary cilia are crit-
ical for the regulation of normal sympathetic activity. Therefore, 
our current study identifies primary cilia expressed in the VMH as a 
key component of normal energy and skeletal homeostasis through 
the regulation of sympathetic nerve activity.
We found that mice lacking the Ift88 gene from SF-1 neurons of 
the VMH developed obesity with a calorimetric decrease in EE. The 
deletion in the VMH is a critical factor for the increased bone mass 
accrual in IFT88-KOSF-1 mice.
Increased osteoblastic and decreased osteoclastic activities in 
IFT88-KOSF-1 mice. SNS activities have previously been linked to 
greater osteoclastic bone resorption by increasing osteoblastic 
RANKL expression (27). In addition, it has been shown that dif-
ferent hypothalamic nuclei influence SNS activity in distinct ways 
(32–34). To gain mechanistic insights into the observed bone den-
sity increment induced by primary cilia deletion in the VMH, we 
first examined genes involved in osteogenic- and osteoclastogen-
ic-related signaling pathways. We found significantly decreased 
expression of Rankl, a key factor of osteoclast differentiation, but 
no change in Rank expression (Figure 7, A and B). In addition, the 
osteoclastic markers tartrate-resistant acid phosphatase (Trap) 
and dendrocyte-expressed 7 transmembrane proteins (Dc-stamp) 
were significantly decreased in IFT88-KOSF-1 mice (Figure 7, C 
and D). Consistent with these results, TRAP-positive cells were 
significantly reduced in IFT88-KOSF-1 femurs (Figure 7, E–G). In 
contrast, the osteogenic markers Sp7 transcription factor (Sp7) 
and alkaline phosphatase (Alp) were increased in femurs of 
IFT88-KOSF-1 mice (Figure 7, H and I). These results imply that the 
high bone mass phenotype in IFT88-KOSF-1 mice might be due to 
a concomitant increase in bone-formation factors and decrease in 
bone-resorption factors. Next, we measured bone turnover mark-
ers, including serum C-terminal telopeptide of type 1 collagen 
(CTX-1) and procollagen type 1 N-terminal propeptide (P1NP). 
We found that serum P1NP was elevated in IFT88-KOSF-1 mice, 
but serum CTX-1 did not change, indicating an increase in osteo-
blast differentiation (Figure 7, J and K). Finally, dynamic histo-
morphometry (calcein double labeling) analysis confirmed the 
increased bone formation and mineral apposition rate (MAR) in 
both cortical and trabecular bones of IFT88-KOSF-1 mice (Figure 
8, A–E). Together, these results demonstrate that the high bone 
density in IFT88-KOSF-1 mice results from increased osteoblastic 
and decreased osteoclastic activities.
Figure 6. VMH primary cilia 
regulate bone homeostasis 
through SNS. (A–D) Changes 
of bone parameters BMD (A), 
BMC (B), BV (C), and BA (D) 
in both WT and IFT88-KOSF-1 
littermates before and after 
i.p. injection of ISO (15 mg/kg) 
for 2 weeks. Bone parame-
ters measured using DEXA 
analysis. *P < 0.05; **P < 0.01, 
2-way ANOVA. (E) Represen-
tative femur images of WT 
and IFT88-KOSF-1 littermates 
after ISO administration. 
(F) The BMD, BV/TV, BS, 
Tb.Th., Tb.N., and Tb.Sp. were 
analyzed using μCT in WT and 
IFT88-KOSF-1 mice given ISO. 
Number of animals examined 
is expressed in parentheses 
in each graph. Results are 
expressed as mean ± SD.
Table 2. Bone parameters measured by DEXA analysis in KD mice
AAV2-GFP AAV2-Cre-GFP
(n = 8) (n = 6)
BMC (g) 0.770 ± 0.042 0.855 ± 0.043A
BMD (g/cm2) 0.093 ± 0.003 0.109 ± 0.013A
BV (cm3) 0.466 ± 0.025 0.517 ± 0.026A
BA (cm2) 8.312 ± 0.319 7.869 ± 0.622
Data are expressed as mean ± SD. AP < 0.01, Student’s t test compared 
with AAV2-GFP control. 
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in ob/ob mice concomitantly altered steroid and pancreatic 
hormones, both factors influencing bone homeostasis (40). 
Therefore, careful attention must be paid to understanding 
leptin’s role in skeletal physiology in particular contexts.
The leptin receptor is widely expressed in several brain 
regions, including the hypothalamus and brain stem (42). 
Thus, it would be interesting to identify leptin’s region- 
specific roles in regulation of skeletal homeostasis. Unfor-
tunately, however, early studies investigating brain region–
specific functions of leptin are primarily focused on energy 
homeostasis (19, 43). As a result, only limited information 
is available for leptin’s brain site–specific role in the regu-
lation of bone homeostasis. Specific leptin receptor dele-
tion in the ARC or VMH did not affect bone density (19, 
43). However, it was suggested that the leptin receptor 
expressed in Tph2-expressing neurons plays an important 
role in regulation of cancellous bone homeostasis, although 
some discrepancies exist in energy homeostasis regulation 
(44, 45). Despite these findings, mice chemically lesioned in the 
VMH using gold thioglucose (GTG) exhibited loss of VMH neu-
rons and showed high bone-density phenotype, highly suggesting 
a possibility that bone homeostatic regulation through the VMH 
might require other components in addition to leptin, such as 
proper neuronal communication between the VMH and its tar-
gets (30). In the present study, the VMH-specific primary cilia KO 
mice showed primary leptin resistance, but this alone might not 
be enough to induce bone remodeling. Therefore, the high bone 
density observed in the IFT88-KOSF-1 mice emphasizes combined 
results of both leptin resistance and SNS decrement. Although we 
showed strong evidence of decreased sympathetic tone in IFT88-
KOSF-1 mice, further examination of the direct mechanism medi-
ating the primary cilia effects on skeletal homeostasis through 
neuronal elements would provide new insight into the function 
of neuronal primary cilia. In addition, it would also be interesting 
to investigate whether primary cilia located in extra VMH regions 
including the ARC, LH, or PVH are involved in regulation of skel-
etal homeostasis as well.
SF-1, a well-known marker of the VMH, is also expressed in 
pituitary gonadotrophs and the major steroidogenic tissues, such 
as the adrenal cortex and testicular Leydig cells (46). Surprisingly, 
primary cilia are not exhibited in SF-1–expressing endocrine cells, 
but are expressed in the pituitary somatotrophs and lactotrophs, 
adrenal capsule and medulla, and immature testis cells, imply-
ing that the primary cilia either would not or would minimally 
decreased EE in IFT88-KOSF-1 mice appeared to be a primary con-
sequence of reduced sympathetic outflow rather than secondary to 
the obesity effect, considering that EE was already decreased when 
the mice were at comparable body weight (Figure 2, A and C–E). 
In addition to the decreased EE, the IFT88-KOSF-1 mice showed 
significantly increased Agrp and decreased Pomc expression in the 
hypothalamus; these genes potentially affect food intake (Figure 
2F and Supplemental Figure 6K). Concomitantly, hyperphagia 
in the IFT88-KOSF-1 mice was evident in the HFD condition (Sup-
plemental Figure 6C). As a contrast to the HFD setting, NC-fed 
IFT88-KOSF-1 mice showed comparable food intake with the WT 
littermates. Therefore, the decreased EE might play an important 
role in leading metabolic disorders of the IFT88-KOSF-1 mice, as the 
KO mice demonstrated an obese phenotype even with comparable 
NC consumption (Figure 1C and Figure 2B).
In addition to metabolic disorders, impaired primary cilia 
function in the VMH resulted in high bone density in the present 
study. Previously, it was suggested that circulating leptin that act-
ed on bone cells stimulated bone growth and formation (35, 36). 
On the other hand, it was believed that leptin action in the CNS 
inhibits bone formation through activation of the SNS (37). While 
these findings suggest that leptin may regulate bone density differ-
ently either in the periphery or the brain, experimental approach-
es using various doses of leptin or supra physiological ob/ob and 
db/db mice may potentially influence other hormones affecting 
skeletal homeostasis (38–41). Indeed, systemic injection of leptin 
Figure 7. Bone parameter changes in VMH-specific primary cilia 
KO mice. (A–D) Expression patterns of genes related to either 
osteoblast or osteoclast differentiation. (E) H&E (left) and TRAP 
chromogenic staining (right) were performed in trabecular bone of 
WT and IFT88-KOSF-1 littermates. Scale bars: 100 μm. (F) Number 
of osteoclasts per BS from E. (G) Amount of osteoclast surface per 
BS from E. (H and I) Relative expression of osteoblastogenic genes. 
(J) Serum P1NP levels of 12-week-old WT and IFT88-KOSF-1 mice. 
(K) Serum CTX-1 levels of 12-week-old WT and IFT88-KOSF-1 mice. 
Number of animals examined is expressed in parentheses in each 
graph. Data are expressed as mean ± SD. *P < 0.05; **P < 0.01; 
***P < 0.001, Student’s t test.
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for proper leptin action (12). However, CAGG-CreER–mediat-
ed IFT88 deletion or Bbs4-KO animals showed leptin resistance 
secondary to obesity. Based on these results, the authors suggest-
ed that leptin signaling is not directly affected by both cilia loss 
(IFT88 KO) and defective cilia signaling (Bbs4 KO) (48). Later, 
the development of minimal leptin resistance was reported when 
cilia were removed from leptin receptor–expressing neurons (12). 
Together with our current results, these data suggest that the 
impact of primary cilia on leptin action may differ from neuron to 
neuron (Figure 3). Therefore, a future goal may be to identify dis-
tinct neuronal populations involved in the maintenance of whole-
body leptin homeostasis.
Another intriguing finding in our study is that the VMH prima-
ry cilia are required for normal sympathetic nerve activity. It has 
been shown that VMH lesions affect sympathetic nervous activity 
and microinjection of glucose into the VMH increases the iBAT 
activity through the SNS (49, 50). In addition, genetic studies have 
also indicated that intact gene expression in the VMH is required 
for proper SNS regulation (13, 19, 22). These studies highlight that 
normal VMH function is necessary for intact SNS regulation. A key 
question regarding sympathetic activity regulation by the VMH 
primary cilia is the role that primary cilia play in this regulation. 
Since we ablated the signaling hub mediated by VMH-primary 
cilia, it is possible that gene expression might be changed in the 
neurons with deleted primary cilia. To investigate this possibility, 
we examined gene expression levels of SF-1, ObRb, and 5-HT2c, 
known factors involved in regulation of SNS activity (Supplemen-
tal Figure 9) (19, 22, 44). Although we could not detect a difference 
in expression levels of those genes, it is still possible to change 
transcriptomes in primary cilia–deleted neurons, which may be 
involved in the regulation of SNS activity. Approaches such as 
whole RNA-Seq after FACS sorting of labeled SF-1 neurons could 
be used to investigate the mechanism behind SNS modulation. In 
addition to the changing of transcriptomes, another possible regu-
lator of SNS activity is the changing character of SF-1 neurons, for 
they lead to impairment in neuronal communication to the sym-
pathetic preganglionic neurons. Indeed, Guo et. al. reported that 
primary cilia are required for proper neuronal circuit formation, 
especially those that affect interneuron morphology, connectivity, 
and synaptic integration. This suggests that cilia deletion in SF-1 
neurons may influence local neuronal circuits (51). Thus, future 
studies could also consider whether neuronal primary cilia are 
involved in the formation of neural circuits specific to the SNS in 
order to determine the functional role of primary cilia in the regu-
lation of SNS activity.
In summary, our study establishes the roles of VMH primary 
cilia in the regulation of energy and skeletal homeostasis through 
sympathetic nerve activity. It provides evidence that VMH ciliary 
signaling directly modulates metabolic parameters, such as leptin 
sensitivity, feeding behaviors, and brown fat function. We report 
that primary cilia are involved in bone homeostasis both locally and 
through neuronal signaling. Thus, proper VMH primary cilia are 
required and indispensable for energy and skeletal homeostasis.
Methods
All animals were maintained in a specific pathogen–free (SPF) facil-
ity. All mouse procedures were maintained on an inbred C57BL/6J 
be affected by SF-1–Cre in the periphery organs (Supplemental 
Figure 3) (16–18). Intact structural integrities of the pituitary and 
adrenal glands, as well as the gonads, together with the functional 
HPA and HPG axes of IFT88-KOSF-1 mice support this notion (Sup-
plemental Figure 4 and Supplemental Table 1). Consequently, the 
metabolic and skeletal phenotypes of IFT88-KOSF-1 mice might be 
the result of VMH primary cilia deletion.
To further rule out potential influence from peripheral pri-
mary cilia and to verify that the IFT88-KOSF-1 phenotypes indeed 
result from the VMH primary cilia, we injected AAV-Cre virus 
directly into the VMH of IFT88fl/fl mice and established VMH- 
specific primary cilia KD models, with the purpose of investigating 
energy and bone homeostasis (Figure 1, I–K, and Figure 4, I and J). 
Interestingly, the AAV-mediated KD mice phenocopied the meta-
bolic and skeletal effects shown in IFT88-KOSF-1 mice (Figure 1 and 
Figure 5). These results confirm that the VMH primary cilia, but 
not the periphery primary cilia exhibited in SF-1–expressing cells, 
are responsible for the observed phenotypes, possibly through the 
regulation of SNS activity. One consideration is that the Cre virus 
will also be expressed in non–SF-1 neurons of the VMH. Therefore, 
it would be interesting to separate which neuronal populations in 
the VMH are mainly involved in the modulation of energy and 
skeletal homeostasis.
One interesting finding in this study is that the VMH prima-
ry cilia are necessary for proper leptin action. The relationship 
between leptin action and the functional involvement of primary 
cilia has long been questioned. Mechanistically, it was suggested 
that Bbs1, a component of the ciliary basal body, directly binds 
to the leptin receptor and is required for proper leptin receptor 
trafficking (47). Interestingly, leptin resistance developed inde-
pendently of obesity only when Bbs1 was deleted in the leptin 
receptor–expressing neurons, suggesting that Bbs1 is required 
Figure 8. Increment of bone growth in VMH-specific primary cilia KO 
mice. (A) Calcein double labeling in cortical bone (upper) and trabecular 
bone (lower). Scale bar: 50 μm. (B and C), BFR (B) and MAR (C) of cortical 
bone of WT and IFT88-KOSF-1 mice. (D and E) BFR (D) and MAR (E) of tra-
becular bone of WT and IFT88-KOSF-1 mice. Ct, cortical bone; Tb, trabecular 
bone. Number of animals examined is expressed in parentheses in each 
graph. Data are expressed as mean ± SD. ***P < 0.001, Student’s t test.
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fixed tissue samples were then paraffin embedded and cut into 4 to 5 
μm slices. To visualize peripheral primary cilia, a regular immunohis-
tochemistry method was performed using the paraffin-embedded tis-
sue samples. After deparaffinization of the tissue samples, the slides 
were brought to a boil in 10 mM sodium citrate buffer (pH 6.0) for 
10 minutes. Then they were washed in PBS, permeated with PBT for 
30 minutes, and blocked by incubating the tissue sections with 3% 
BSA in PBT for 1 hour at RT. Primary antibodies diluted in PBT-azide 
containing 3% BSA were added, then slides were incubated overnight 
at 4°C. The following day, tissue samples were rinsed with PBS and 
incubated for 2 hours in secondary antibodies. Then the sections were 
rinsed and a coverslip was placed on the tissue sections using mount-
ing medium with DAPI. Slides were visualized using a confocal laser 
microscope (LSM700), and analysis was processed using the ZEN 
blue software (Zeiss).
The primary antibodies used were as follows rabbit anti-ACIII 
(catalog sc-588, 1:2000, Santa Cruz Biotechnology Inc.), goat anti-
SSTR3 (catalog sc-11617, 1:500, Santa Cruz Biotechnology Inc.), and 
mouse anti-Ac-Tub (acetylated α-tubulin, catalog T7451, 1:500, Milli-
poreSigma) for primary cilia and chicken anti-GFP (catalog GFP-1020, 
1:10000, AvesLab) for either viral infection or SF-1–EGFP–positive cells.
Secondary antibodies used were as follows: Alexa Fluor 488–con-
jugated goat anti-rabbit antibody (catalog A21206, 1:1000), Alexa 
Fluor 594–conjugated goat anti-rabbit antibody (catalog A11012, 
1:1000), Alexa Fluor 594–conjugated goat anti-mouse antibody (cat-
alog A11005, 1:1000), Alexa Fluor 594–conjugated donkey anti-goat 
antibody (catalog A11058, 1:1000) from Invitrogen, and Alexa Flu-
or 488–conjugated donkey anti-chicken IgY†† (catalog 703-545-155, 
1:5000, Jackson Immune Research).
Cresyl violet staining (Nissl staining) was performed to exam-
ine overall neuron structure. Briefly, brain sections were embedded 
in Superfrost Plus microscope slides (Fisher Scientific), and sections 
were left to dry at RT. After rinsing the sections in distilled water, 
slides were dipped in 0.1% cresyl violet solution for about 10 minutes. 
Then slides were rinsed in distilled water and differentiated in 90% 
and 95% ethanol for 3 minutes each. Afterwards, slides were dehy-
drated in absolute ethanol 2 times for 3 minutes each and were dipped 
in 100% xylene 3 times for 5 minutes each. Finally, slides were mount-
ed with mounting media and checked under the microscope.
Body weight and compositions. The body weights of WT and IFT88-
KOSF-1 mice were monitored weekly from weaning (4 weeks old). For 
the HFD study, WT and IFT88-KOSF-1 littermates were maintained on 
the regular chow diet until they were 8 weeks old, then were switched 
to HFD for an additional 12 to 16 weeks. Body weight measurement for 
AAV-injected KD mice started from 1 week after stereotaxic surgery. 
Body compositions of all mice were analyzed by nuclear magnetic res-
onance (NMR) (LF90 Minispec, Bruker Corp.).
Metabolic cage study. For metabolic cage studies, weight-matched 
12-week-old WT (30.10 ± 1.11 g) and IFT88-KOSF-1 (31.30 ± 1.33 g) male 
littermates fed NC were used and 16-week-old WT (46.63.10 ± 1.78 
g) and IFT88-KOSF-1 (53.40 ± 2.21 g) male littermates fed HFD were 
used. Metabolic rates were assessed with an indirect calorimetry sys-
tem (CaloSys Calorimetry System, TSE Systems Inc.), as previously 
described (20, 24). For environmental acclimation, first, the experi-
mental mice were housed 5 days in metabolic cages individually and 
maintained in the same room where the metabolic analyses were 
performed. Then the mice were individually housed in the metabolic 
genetic background and were housed under controlled room tem-
perature (RT) (22–24°C) with a 12-hour light/12-hour dark cycle (light 
on at 8:00 am), with free access to either NC (PicoLab Rodent Diet 
20, 0007688; 13% from fat, 3.03 kcal·g-1) or HFD (Research Diets, 
#D12492; 60% from fat, 5.24 kcal·g-1) and water.
Mouse models. To generate experimental mice, IFT88-KOSF-1 male 
mice heterozygous for the SF-1–Cre transgene and homozygous for the 
floxed Ift88 allele (Ift88fl/fl) were crossed with female mice (Jackson 
Laboratory stock no. 022409) homozygous for the floxed Ift88 allele 
(Ift88fl/fl). The littermate mice homozygous for the floxed Ift88 allele 
(Ift88fl/fl) served as controls (WT).
The primers used for genotyping PCR were as follows: SF-1–Cre: 
forward (F), 5′-CTGAGCTGCAGCGCAGGGACAT-3′, reverse (R), 
5′-TGCGAACCTCATCACTCGTTGCAT-3′; WT: F, 5′-GGTCAG-
CCTAATTAGCTCTGTCAT-3′, R, 5′-GATCTCCAGCTCCTCCTCT-
GTCT-3′; Ift88 floxed: F, 5′-GACCACCTTTTTAGCCTCCTG-3′, R, 
5′-AGGGAAGGGACTTAGGAATGA-3′.
To generate VMH-specific primary cilia KD mice, 10- to 12-week 
old Ift88fl/fl male mice were used for stereotaxic surgery. Anesthetics 
were prepared by mixing Zoletil (30 mg/kg) and Rompun (10 mg/kg) 
in isotonic saline. Then the mixture was i.p. injected into the mice at 
10 μL/g of body weight. Animals were placed into a stereotaxic appa-
ratus (Kopf 1900) under sterile conditions. A small incision was made 
to expose the skull and drilled at the injection site. To target the injec-
tion site, a 3D MRI coordinate system was used as a reference. The 
coordinates for VMH were anterior-posterior: –4.80 mm, mediolater-
al: ±0.50 mm, and dorsal-ventral: –4.83 mm (500 nL injection). Viral 
constructs were injected at a rate of 50 nL/min for 10 minutes, and the 
injector remained in place for an additional 5 minutes before remov-
al. After surgery, mice were placed on a heating pad for recovery. AAV 
expressing Cre-GFP (catalog 105545, AAV2-Cre-GFP) and GFP (cata-
log 105530, AAV2-GFP) were purchased from Addgene.
Validation of mouse models. To validate the specific deletion or KD 
of primary cilia in the VMH, mice were perfused and their brains were 
collected. Mice were i.p. injected with Avertin (tribromoethanol, 25 mg/
kg of body weight) for anesthesia, then transcardially perfused with 20 
mL of PBS (pH7.4) and fixed with 20 mL of 10% neutral buffered for-
malin. Brains were dissected out and post-fixed in 10% neutral buffered 
formalin for 2 hours at RT, then were transferred to 20% of sucrose in 
PBS overnight at 4°C for cryoprotection. Brains were sliced into 20 μm 
sections using a sliding microtome (Leica SM2010, Leica Biosystems).
To visualize neuronal primary cilia, immunohistochemistry was 
performed using the free-floating method. Briefly, brain sections were 
washed in PBS and permeated with 0.25% Triton X-100 in PBS (v/v) 
for 30 minutes. After blocking with 3% goat serum prepared in PBS 
containing 0.25% Triton X-100 (PBT) for 1 hour at RT, the brain sec-
tions were incubated for 36 hours at 4°C with primary antibodies in 
PBT-azide containing 3% (v/v) goat serum. Then sections were rinsed 
with PBS 3 times and incubated for 2 hours in secondary antibodies 
diluted in PBT containing 3% (v/v) goat serum at RT. Afterwards, sec-
tions were rinsed and mounted on glass slides using mounting medi-
um with DAPI (catalog H-1500, Vector Laboratories) and visualized 
by a confocal laser microscope (LSM700, Carl Zeiss AG). Further 
analysis was done using ZEN blue software (Zeiss) and ImageJ (NIH).
To evaluate any effects of peripheral primary cilia by SF-1–Cre, 
mice were perfused and the tissues known to express SF-1, including 
pituitary and adrenal glands, testis, and ovary, were collected. Post-
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(0.01N HCl, 0.15 mM EDTA, 0.1% reduced l-glutathione) and neu-
tralized with 1.0M Tris pH 8.0 (1/10 vol) prior to NE ELISA. Extracted 
serum and femur NE were acylated and then converted enzymatically 
before being quantitatively determined. Levels were determined by a 
competitive enzyme immunoassay method using commercial ELISA 
kits (BA-E-5200, Labor Diagnostika Nord GmbH & Co.) following the 
manufacturer’s instructions. Aliquot of femur suspended in extraction 
buffer was used to quantify protein concentration and to normalize 
femur NE measurements.
Glucose and insulin tolerance tests. For glucose tolerance test (GTT), 
12-week old mice were fasted overnight for 18 hours and provided with 
water ad libitum. The next day, mice were housed in individual cages 
and allowed to acclimate for 2 hours followed by i.p. injection of 1.0 g 
kg−1 glucose (G8270, MilliporeSigma). For insulin tolerance test (ITT), 
mice were fasted for 2 hours in individual cages with free access to 
water. Insulin (0.8 U kg−1, Eli Lilly and Co.) was administered by i.p. 
injection. Blood samples were obtained from a tail nick, and blood glu-
cose was measured at 0, 15, 30, 45, 60, 90, 120, and 150 minutes using 
a commercial glucometer (Contour TS, Ascensia Diabetes Care).
Bone densitometry (DEXA). WT and IFT88-KOSF-1 male littermates 
were examined for whole-body fat and lean masses, BMD, BMC, BV, and 
BA using DEXA (InAlyzer, MEDIKORS) under light isoflurane anesthe-
sia for about 1 minute. The detection sensitivity of the DEXA instrument 
was 0.001 g/cm2. A standard calibration block was used to calibrate the 
DEXA device before measurements in accordance with the operator’s 
manual. Software integrated to the scan was used for data analysis.
μCT)analysis. The right femur from each mouse was dissected and 
fixed overnight in 10% neutral buffered formalin, loaded into 12.3 mm 
diameter scanning tubes, and imaged using a desk-top μCT scanner 
(SkyScan 1076, Bruker Micro CT). The scans were integrated into 3D 
voxel images and a region of interest (ROI) that consisted of 100 slices 
starting from about 0.5 mm proximal to growth plate, constituting 1.6 
mm in length, was chosen for analysis. The following 3D indices in the 
defined ROI were analyzed, including total tissue volume, BV, BV/TV, 
Tb.N., Tb.Th., and Tb.Sp.
ISO treatment. For ISO treatment, 14-week-old WT and IFT88-
KOSF-1 male littermates were used. Prior to treatment, mice were exam-
ined for fat and lean mass, BMD, BMC, BV, and BA using DEXA. After 
2 days of recovery, mice were given ISO (15 mg/kg of body weight, 
daily i.p. injection) for 2 weeks. After 2 weeks, mice were measured 
again for fat and lean mass and bone parameters.
Immunohistochemistry and H&E staining. For SF-1 staining, brain 
sections were mounted on Superfrost Plus microscope slides (Fisher 
Scientific), then dried overnight. The following day, samples were 
pretreated with 0.3% hydrogen peroxide in PBS (pH 7.4) for 30 min-
utes at RT; then antigen retrieval was done for 5 minutes. Samples 
were blocked in 3% normal donkey serum, then incubated with rab-
bit anti–SF-1 antibody (22, 52) overnight at 4°C. After washing in PBS, 
sections were incubated in biotinylated donkey anti-rabbit IgG (065-
152, 1:1000, Jackson ImmnuoResearch) for 2 hours at RT, followed by 
incubation for 1 hour in a solution of avidin-biotin complex (Vectastain 
Universal ABC Kit, PK-6200, Vector Laboratories). Sections were next 
washed in PBS and stained with DAB-peroxidase substrate solution 
(0.04% DAB and 0.01% H2O2) in PBS. The stained slides were visual-
ized by a Nikon Digital Camera DXM1200 microscope system.
For UCP1 staining, iBAT was sectioned and paraffin embedded. 
The sections were incubated with primary UCP1 antibody (catalog 
chambers and acclimated for 48 hours. After acclimation in the cham-
ber, food intake, oxygen consumption (VO2), carbon dioxide produc-
tion (VCO2), heat generation, and movement were measured and the 
relationship between metabolic rate and body mass was normalized 
using lean body mass. Diet (NC or HFD) and water were available ad 
libitum unless otherwise indicated.
To measure leptin sensitivity using metabolic cages, body weight 
matched (28.54 ± 1.39 g for WT and 29.33 ± 1.10 g for IFT88-KOSF-1) 
12-week old mice were used. After 3 days of regular cage studies, chow 
was removed at 6:00 pm, and mice were fasted for 1 day. The follow-
ing day, experimental mice were given leptin (i.p., 5 mg/kg of body 
weight) with food; then metabolic parameters, including food intake, 
VO2, VCO2, heat generation, and movement, were monitored during 
the experimental period.
To assess the metabolic effects of ISO (I6504, MilliporeSigma), 
an adrenoreceptor agonist, 16-week old WT and IFT88-KOSF-1 mice 
were used and were given ISO (15 mg/kg of body weight, daily i.p. 
injection) for 2 weeks.
Rebound food intake. For the rebound feeding experiments, 10- to 
12- week-old mice were fasted overnight for 18 hours with water pro-
vided ad libitum. The following day, mice were given the same amount 
of food; then food intake and body weight were recorded at the indi-
cated time points. To assess leptin sensitivity, 12-week-old WT and 
IFT88-KOSF-1 mice were given either saline or leptin (5 mg/kg of body 
weight) via i.p. injection after an overnight fast. Refeeding food intake 
and body weight were recorded at the indicated time points.
Hypothalamic p-STAT3 staining. For p-STAT3 immunohistochem-
istry, weight-matched 10-week-old WT and IFT88-KOSF-1 mice fasted 
for 24 hours were given leptin (5 mg/kg of body weight) or saline. After 
1 hour, animals were transcardially perfused with 10% neutral buff-
ered formalin. Rabbit anti–p-STAT3 antibody (catalog 9131, 1:1000, 
Cell Signaling Technology) was used and regular immunohistochem-
istry was followed, as described elsewhere.
Serum analyses. To measure fed glucose levels, mice were accli-
mated for 2 hours in the experimental area before measurement. Then 
a small drop of blood was obtained from tail nick and measured with a 
glucometer (Contour TS, Ascensia Diabetes Care).
For insulin and leptin measurement, blood was collected from the 
tail-nick after 2 hours of acclimation in the experiment area. Serum 
was analyzed with specific ELISA kits (Morinaga Institute of Biological 
Science) in accordance with the manufacturer’s instructions.
For corticosterone, aldosterone, and E2 measurements, mice 
were either housed in a group or individually, and blood samples were 
collected at 2:00 pm. An acclimation period of 3 days was given to the 
mice caged individually. Corticosterone and aldosterone levels were 
measured using an ELISA kit obtained from Abcam (ab108821 and 
ab136933, respectively). Plasma E2 was measured using ELISA kits 
(3830, BioVision Inc.).
For serum P1NP and CTX-1 measurements, blood samples were 
collected from 12-week-old WT and IFT88-KOSF-1 male littermates 
at 2:00 pm. P1NP and CTX-1 were measured using commercial kits 
(AC-33F1 for P1NP, and AC-06F1 for CTX-1, Immunodiagnostic Sys-
tems) in accordance with the manufacturer’s instructions.
NE measurements. For serum NE, blood was collected from the 
tail of 8- to 14-week old male mice at 2-week intervals. For femur NE, 
male mice were sacrificed and right femurs were dissected. Frozen 
femur powder was resuspended in glutathione tissue extraction buffer 
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ized to genomic DNA by amplification of the 40S ribosomal protein 
s18 (Rps18) nuclear gene (53). Primers used were as follows: mouse 
COX2: F, 5′-ATAACCGAGTCGTTCTGCCAAT-3′, R, 5′-TTTCAGAG-
CATTGGCCATAGAA-3′; Rps18: F, 5′-TGTGTTAGGGGACTGGTGG-
ACA-3′, R, 5′-CATCACCCACTTACCCCCAAAA-3′.
RNA isolation and real-time qPCR. Total RNA was extracted from 
tissue samples (hypothalamus, liver, iBAT, and femur) using TRIzol 
reagent (Life Technologies) following the manufacturer’s instructions; 
1 μg of total RNA was used to synthesize cDNA using the ReverTra Ace 
qPCR RT Master Mix with gDNA Remover (TOYOBO). An aliquot 
(1/100 vol) of the cDNA was then subjected to real-time quantitative 
PCR (qPCR) using iQ SYBR Green Supermix (Bio-Rad) in a 96-well 
real-time PCR machine (CFX96, Bio-Rad). Fold changes were calcu-
lated and determined using the 2-ΔΔCt method and expression levels 
normalized to the average of the housekeeping genes 18S or HRPT.
Primers used were as follows: mouse Pomc: F, 5′-CAGGTCCT-
GGAGTCCGAC-3′, R, 5′-CATGAAGCCACCGTAACG-3′; Npy: 
F, 5′-CTACTCCGCTCTGCGACACT-3′, R, 5′-AGTGTCTCAGG-
GCTGGATCTC-3′; Agrp: F, 5′-CGGCCACGAACCTCTGTAG-3′, 
R, 5′-CTCATCCCCTGCCTTTGC-3′; SF-1: F, 5′-CCCTTATCCG-
GCTGAGAATT-3′, R, 5′-CCAGGTCCTCGTCGTACGA-3′; ObRb: F, 
5′-AACCCCAAGAATTGTTCCTGG-3′, R, 5′-GGAGACCATAGCT-
GCTGGGACC-3′; 5-HT2c: F, 5′-GCCAATGAACACCTTCTTTCC-3′, 
R, 5′-GCCAATTAGGTGCACAAGGAG-3′; Ucp1: F, 5′-GGCCCTTG-
TAAACAACAAAATAC-3′, R, 5′-GGCAACAAGAGCTGACAG-
TAAAT-3′; Pgc1α: F, 5′-AACCACACCCACAGGATCAGA-3′, R, 
5′-TCTTCGCTTTATTGCTCCATGA-3′; Dio2: F, 5′-TTCTCCAACT-
GCCTCTTCCTG-3′, R, 5′-CCCATCAGCGGTCTTCTCC-3′; Tfam: 
F, 5′-AGGAGGCAAAGGATGATTCG-3′, R, 5′-CCTCAGGAGA-
CAGATTTTTCCA-3′; Pklr: F, 5′-AGGAGTCTTCCCCTTGCTC-
TAC-3′, R, 5′-GGAGAGGCGTTTCAGGATATG-3′; PEPCK: F, 
5′-CGCAAGCTGAAGAAATATGACAA-3′, R, 5′-TCGATCCTG-
GCCACATCTC-3′; G6Pase: F, 5′-TGGGCAAAATGGCAAGGA-3′, 
R, 5′-TCTGCCCCAGGAATCAAAAAT-3′; Ehhadh: F, 5′-CTTG-
GAATTCTGGATGTAG-3′, R, 5′-TGGGTTTACCTATAACCG-3′; 
PPARγ: F, 5′-CAAGAATACCAAAGTGCGATCAA-3′, R, 5′-GAGCT-
GGGTCTTTTCAGAATAATAAG-3′; Srebp1: F, 5′-GGAGCCATG-
GATTGCACATT-3′, R, 5′-GGCCCGGGAAGTCACTGT-3′; FASN: 
F, 5′-GGTGTGGTGGGTTTGGTGAATTGT-3′, R, 5′-TCACGAG-
GTCATGCTTTAGCACCT-3′; HSL: F, 5′-GCGCTGGAGGAGT-
GTTTTT-3′, R, 5′-CCGCTCTCCAGTTGAACC-3′; Rank: F, 
5′-CCAGGAGAGGCATTATGAGCA-3′, R, 5′-ACTGTCGGAGG-
TAGGAGTGC-3′; Rankl: F, 5′-CAGCATCGCTCTGTTCCTGTA-3′, 
R, 5′-CTGCGTTTTCATGGAGTCTCA-3′; Trap: F, 5′-GCAACATC-
CCCTGGTATGTG-3′, R, 5′-GCAAACGGTAGTAAGGGCTG-3′; 
Dc-Stamp: F, 5′-GGGGACTTATGTGTTTCCACG-3′, R, 5′-ACAAAG-
CAACAGACTCCCAAAT-3′; Sp7: F, 5′-TCCCTGGATATGACTCATC-
CCT-3′, R, 5′-CCAAGGAGTAGGTGTGTTGCC-3′; Alp: F, 5′-CCTT-
GAAAAATGCCCTGAAA-3′, R, 5′-TTACTGTGGAGACGCCCATA-3′; 
18S: F, 5′-AACCCGTTGAACCCCATT-3′, R, 5′-CCATCCAATCGG-
TAGTAGCG-3′; and HRPT: F, 5′-CTCATGGACTGATTATGGACAG-
GAC-3′, R, 5′-GCAGGTCAGCAAAGAACTTATAGCC-3′.
Statistics. All statistical tests for data values were conducted using 
GraphPad Prism (version 5) and R software (version 3.6.0). Full details 
of each statistical test used are provided in each figure legend. P val-
ues of less than 0.05 were defined a statistically significant. Statisti-
cal significance was determined by unpaired 2-tailed Student’s t test 
ab10983, 1:1000, Abcam) at 4°C for 24 hours. Slides were washed 5 
times with PBS and then incubated with secondary antibody for and 
additional 2 hours using the Vectastain Universal ABC Kit. After wash-
ing 3 times in PBS for 10 minutes each, slides were then stained with 
DAB-peroxidase substrate solution. Stained slides were visualized by 
a Nikon Digital Camera DXM1200 microscope system.
Peripheral tissues including WAT, BAT, liver, pituitary, adrenal 
gland, testis, ovary, and femurs were dissected and post-fixed over-
night at 4°C. Tissue samples were then paraffin embedded and cut 
into 4 μm slices. Slices were stained with H&E following the stan-
dard H&E procedure.
Dynamic bone histomorphometry. The left femur from each animal 
was dissected and fixed in 10% neutral buffered formalin. Samples 
were decalcified in ChelatorCal (BBC Biochemical) and embedded 
in paraffin, then cut into 4 μm slices. Femur sections were stained by 
either H&E or TRAP for osteoclast analysis. TRAP staining was carried 
out with the TRAP Stain Kit (TRAP/ALP Stain Kit, Wako Pure Chem-
ical Industries Ltd.). Deparaffinized and rehydrated sections were 
incubated at 37°C for 30 minutes in TRAP substrate buffer, and then 
slides were mounted with VectaMount (Vector Laboratories). Images 
were visualized with an Olympus IX71/F22PH microscope and mea-
surements performed with Bio-Quant software. The TRAP-positive 
osteoclast number (N. Oc) and surface (Oc.S) were normalized with BS.
To determine bone-formation rate (BFR) and mineralization, 
6-week-old male mice were injected with 10 mg/kg calcein (Milli-
poreSigma) dissolved in 2.0% sodium bicarbonate (pH 7.0) 2 times a 
day for 7 days. Bones were fixed in 4% formalin. Femurs were embed-
ded in paraffin blocks and sectioned to be 4 μm thick. Before histo-
morphometric analysis, femur metaphyseal sections were viewed with 
a fluorescent Nikon Digital Camera DXM1200 Microscope System, 
and 5 digital images per section were taken. The distance between the 
calcein lines (MAR) and the length of the calcein lines (mineralized 
surface) along the BS were measured to calculate BFR using ImageJ.
Western blot analysis. Tissues samples were lysed in RIPA buffer 
(150 mM NaCl, 50 mM Tris pH 8.0, 1% Triton X-100, 0.5% sodium 
deoxycholate, and 0.1% SDS) containing protease and phosphatase 
inhibitors (Roche). Protein extracts were obtained by centrifugation 
at 13,000g for 15 minutes at 4°C. Protein concentration was mea-
sured using Bio-Rad Protein Assay reagent (500006, Bio-Rad). Equal 
amounts of protein were loaded and separated on SDS/PAGE gels 
and transferred to PVDF membranes (Millipore). Then membranes 
were incubated with specific antibodies in TBS with 0.1% Tween-20 
(TBST) overnight at 4°C. Primary antibodies used were rabbit anti-
UCP1 (catalog ab10983, 1:10000, Abcam), STAT3 (catalog 9139, 
1:5000, Cell Signaling Technology), and rabbit anti-β actin (catalog 
GTX109639, 1:5000, GeneTex). Secondary antibodies conjugated to 
HRP were added for 1 hour at RT. Secondary antibody used was goat 
anti-rabbit IgG-HRP (catalog 31460, 1:5000, Thermo Fisher Scientif-
ic). Protein levels were detected using Pierce ECL Western blotting 
substrate following the standard Western blot procedure, and blots 
were visualized using the chemiluminescent image analyzer LAS 
4000 (GE Healthcare Life Science).
Mitochondria contents in the iBAT. For mitochondrial DNA con-
tent analysis, total DNA from iBAT was extracted using DNAzol 
Reagent (Invitrogen) according to the manufacturer’s instructions. 
Mitochondrial DNA was amplified using primers specific for the mito-
chondrial cytochrome C oxidase subunit 2 (COX2) gene and normal-
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